Wright Foot & Ankle Post-Market Observational Study

Sponsor
Stryker Trauma GmbH (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT04118894
Collaborator
(none)
125
5
167.3
25
0.1

Study Details

Study Description

Brief Summary

WRIGHT FOOT & ANKLE POST-MARKET OBSERVATIONAL STUDY, Multi-Year, Multi-Site, Multi-Device, Post-Market Observational Study, 10 sites, a minimum of 40 patients per device

Condition or Disease Intervention/Treatment Phase
  • Device: Foot and Ankle Devices

Detailed Description

The selected design is a global, multi-center, non-randomized, prospective observational study. The study subjects included are those treated with one or more approved or cleared Wright Medical products included in this study.

Study Design

Study Type:
Observational
Actual Enrollment :
125 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Wright Foot & Ankle Post-Market Observational Study
Actual Study Start Date :
Jan 22, 2020
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2034

Arms and Interventions

Arm Intervention/Treatment
Foot and Ankle Devices

The study subjects included are those treated with one or more approved or cleared Wright Medical products included in this study.

Device: Foot and Ankle Devices
Wright devices used in foot and ankle procedures

Outcome Measures

Primary Outcome Measures

  1. EuroQol (EQ-5D-5L). [1 year]

    Comparing the changes in patient-reported pain and social interaction for quality of life from pre-op through post-operatively, assessed by the EuroQol (EQ-5D-5L). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. This decision results in a 1-digit number that expresses the level selected for that dimension. Health utility values generated from the EQ-5D generally range from 0 (death) to 1 (perfect health). But health utility values less than 0 are possible, and represent health states considered worse than death. The EQ VAS records the patient's self-rated health on a VAS (0-100), where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.

Secondary Outcome Measures

  1. Foot and Ankle Ability Measure (FAAM) [1 year]

    Comparing the changes in patient-reported function scores from pre-op through post-operatively, assessed by the FAAM The FAAM is a patient-completed instrument that consists of an "Activities of Daily Living" subscale (21 scored items) and a "Sports" subscale (7 scored items) in which the response options are presented as 5-point Likert scales (range 4 to 0). Scores for each subscale range from 0% (least function) to 100% (most function).

  2. Safety Assessment [1 year]

    Identifying and reporting the safety of the implant in terms of complications and adverse events.

  3. Surgeon Survey [1 year]

    Conducting a surgeon survey including radiographic assessment of fusion and consolidation time

  4. Patient Survey [1 year]

    Conducting patient surveys to assess current implant status (to include complications)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Willing and able to consent to participate (written, informed consent);

  • Willing and able to attend/complete the requested follow-up visits;

  • Considered for treatment with one or more approved or cleared Wright Medical products included in this study

Exclusion Criteria:
  • Subjects determined, by the investigator, to be an inappropriate candidate for the procedure indicated;

  • Unable to consent to participate (written, informed consent);

  • Unable to attend/complete the requested follow-up visits

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mercer-Bucks Orthopaedics Hamilton New Jersey United States 08691
2 OrthoCarolina Charlotte North Carolina United States 28207
3 CHRU Tours, Hôpital Trousseau Tours France 37044
4 Hessingpark Clinic Augsburg Germany
5 Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust Oswestry Shropshire United Kingdom

Sponsors and Collaborators

  • Stryker Trauma GmbH

Investigators

  • Study Director: Rebecca Gibson, Stryker Nordic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stryker Trauma GmbH
ClinicalTrials.gov Identifier:
NCT04118894
Other Study ID Numbers:
  • INT19-MDR-001
First Posted:
Oct 8, 2019
Last Update Posted:
Feb 3, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 3, 2022